Human Immunodeficiency Virus Type 1 Nef Protein Mediates Neural Cell Death: a Neurotoxic Role for IP-10
Overview
Authors
Affiliations
HIV-1 Nef is expressed in astrocytes, but a contribution to neuropathogenesis and the development of HIV-associated dementia (HAD) remains uncertain. To determine the neuropathogenic actions of the HIV-1 Nef protein, the brain-derived (YU-2) and blood-derived (NL4-3) Nef proteins were expressed in neural cells using an alphavirus vector, which resulted in astrocyte death (P < 0.001). Supernatants from Nef-expressing astrocytes also caused neuronal death, suggesting the release of neurotoxic molecules by astrocytes. Analysis of pro-inflammatory gene induction in astrocytes expressing Nef revealed increased IP-10 mRNA expression (4000-fold) that was Nef sequence dependent. Recombinant IP-10 caused selective cell death in neurons (P < 0.001) but not astrocytes, and the cytotoxicity of supernatant from astrocytes expressing Nef YU-2 was blocked by an antibody directed against the chemokine receptor CXCR3 (P < 0.001). SCID/NOD mice implanted with a Nef YU-2-expressing vector displayed abnormal motor behavior (P < 0.05), neuroinflammation, and neuronal loss relative to controls. Analysis of mRNA levels in brains from patients with HAD also revealed increased expression of IP-10 (P < 0.05), which was confirmed by immunoreactivity detected principally in astrocytes. Phylogenetic and protein structure analyses of Nef sequences derived from HIV/AIDS patients with and without HAD suggested viral evolution toward a neurotropic Nef protein. These results indicate that HIV-1 Nef contributes to neuropathogenesis by directly causing astrocyte death together with indirect neuronal death through the cytotoxic actions of IP-10 on neurons. Furthermore, Nef molecular diversity was evident in brain tissue among patients with neurological disease and which may influence IP-10 production by astrocytes.
Kim C, Kim J, Yoon S, Yi I, Lee H, Seo S Front Vet Sci. 2024; 11:1390296.
PMID: 39170638 PMC: 11335684. DOI: 10.3389/fvets.2024.1390296.
Boreland A, Stillitano A, Lin H, Abbo Y, Hart R, Jiang P iScience. 2024; 27(5):109628.
PMID: 38628961 PMC: 11019286. DOI: 10.1016/j.isci.2024.109628.
Boreland A, Stillitano A, Lin H, Abbo Y, Hart R, Jiang P bioRxiv. 2023; .
PMID: 37961371 PMC: 10634901. DOI: 10.1101/2023.10.25.563950.
Neuro-HIV-New insights into pathogenesis and emerging therapeutic targets.
Sviridov D, Bukrinsky M FASEB J. 2023; 37(12):e23301.
PMID: 37942865 PMC: 11032165. DOI: 10.1096/fj.202301239RR.
Williams M, Williams A, Naude P BMC Infect Dis. 2023; 23(1):512.
PMID: 37545000 PMC: 10405499. DOI: 10.1186/s12879-023-08495-3.